Involvement of supraspinal GABAergic systems in clonidine-induced antinociception in the tail-pinch test in mice

Life Sciences

Volumn 61, Issue 11, 1997, Pages 1097-1103

  Huong, Nguyen Thi Thu ^a   Matsumoto, Kinzo ^a   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Antinociception; Clonidine; GABA(A) receptor; GABA(B) receptor

Indexed keywords

2 HYDROXYSACLOFEN; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BACLOFEN; BICUCULLINE; CLONIDINE; MUSCIMOL; PICROTOXIN; 2-HYDROXYSACLOFEN; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ANALGESIC AGENT; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GABAERGIC SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG POTENTIATION; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; TAIL;

ANALGESICS; ANIMALS; BACLOFEN; BICUCULLINE; CLONIDINE; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MUSCIMOL; PAIN; PICROTOXIN; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, GABA; TAIL;

EID: 0030820292     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00618-8     Document Type: Article

References (28)

1. Y. KURAISHI, Y. HARADA, S. ARATANI, M. SATOH and H. TAKAGI, Brain Res. 273 245-252 (1983).
2. S. WIGDOR and G. L. WILCOX, J. Pharmacol. Exp. Ther. 242 90-95 (1987).
3. T. L. YAKSH, D. L. HAMMOND and G. M. TYCE, Fed. Proc. 40 2786-2794 (1981).
4. H. K. PROUDFIT, Prog. Brain Res. 77 357-370 (1988).
5. S. V. R. REDDY, J. L. MADERDRUT and T. L. YAKSH, J. Pharmacol. Exp. Ther. 213 525-533 (1980).
6. S. FIELDING, T. C. SPAULDING and H. LAUL, Antinociceptive Actions of Clonidine, H. LAL and S. FIELDING (Eds), 225-242, Alan R. Liss, New York (1981).
7. M. SKINGLE, A. G. HAYES and M. B. TYERS, Life Sci. 31 1123-1132 (1982).
8. J. SAWYNOK, Pharmacol. Biochem. Behav. 26 463-474 (1987).
9. M. INOUE, T. MATSUO and N. OGATA, Br. J. Pharmacol. 84 833-841 (1985).
10. A. PITTALUGA and M. RAITERI, J. Pharmacol. Exp. Ther. 245 682-686 (1988).
11. M. K. MCGOWAN and D. L. HAMMOND, Brain Res. 607 39-46 (1993).
12. M. K. MCGOWAN and D. L. HAMMOND, Brain Res. 620 86-96 (1993).
13. J. J. RADY and J. M. FUJIMOTO, Pharmacol. Biochem. Behav. 51 655-659 (1995).
14. K. PRZESMYCKI, J. DZIECIUCH and Z. KLEINROK, Pol. J. Pharmacol. 46 409-415 (1994).
15. T. NABESHIMA, K. MATSUNO, A. SUGIMOTO and T. KAMEYAMA, Neuropharmacology 26 1453-1455 (1987).
16. T. J. HALEY and W. G. MCCORMICK, Br. J. Pharmacol. 12 12-15 (1957).
17. K. MATSUMOTO, M. MIZOWAKI, S. THONGPRADITCHOTE, Y. MURAKAMI, H. TAKAYAMA, S.-I. SAKAI, N. AIMI and H. WATANABE, Eur. J. Pharmacol. 317 75-81 (1996).
18. K. MATSUMOTO, M. MIZOWAKI, S. THONGPRADITCHOTE, Y. MURAKAMI and H. WATANABE, Life Sci. 59 1149-1155 (1996).
19. N. T. T. HUONG, K. MATSUMOTO, K. YAMASAKI, N. M. DUC, N. T. NHAM and H. WATANABE, Pharmacol. Biochem. Behav. 52 427-432 (1995).
20. W. L. DEWEY, L. S. HARRIS, J. F. HOWES and J. A. NUITE, J. Pharmacol. Exp. Ther. 175 435-442 (1970).
21. A. KAWABATA, K. KASAMATSU, N. UMEDA and H. TAKAGI, Br. J. Pharmacol. 111 503-508 (1994).
22. T. C. SPAULDING, J. J. VENAFRO, M. G. MA and S. FIELDING, Neuropharmacology 18 103-105 (1979).
23. S. P. SIVAM and I. K. HO, Life Sci. 37 199-208 (1985).
24. Q. LIN, Y. PENG and W. D. WILLIS, Brain Res. 654 286-302 (1994).
25. S. ARAN and D. L. HAMMOND, J. Pharmacol. Exp. Ther. 257 360-368 (1991).
26. M. MALCANGIO, C. GHELARDINI, A. GIOTTI, P. MALMBERG-AIELLO and A. BARTOLINI, Br. J. Pharmacol. 103 1303-1308 (1991).
27. R. NADESON, Z. GUO, V. PORTER, J. P. GENT and C. S. GOODCHILD, J. Pharmacol. Exp. Ther. 278 620-626 (1996).
28. D. M. DIRIG and T. L. YAKSH, J. Pharmacol. Exp. Ther. 275 219-227 (1995).